ALLK - Allakos Inc
0.3291
0.000 -0.061%
Share volume: 725,841
Last Updated: 05-14-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.33
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-06-2024 | 03-12-2025 | 05-07-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 45.722 M | 28.633 M | 19.750 M | 24.656 M | 26.710 M | |
| Selling general and admin | 10.898 M | 9.211 M | 8.876 M | 9.837 M | 13.178 M | |
| Research and development | 34.824 M | 19.422 M | 10.874 M | 14.819 M | 13.532 M | |
| Total expenses | 73.069 M | 28.633 M | 19.750 M | 773.000 K | 26.710 M | |
| -60.81% | -31.02% | -96.09% | 3,355.37% | |||
| Operating income | -73.069 M | -28.633 M | -19.750 M | -773.000 K | -26.710 M | |
| Ebit | -73.141 M | -28.635 M | -19.764 M | -728.000 K | -26.925 M | |
| Pretax income | -71.146 M | -26.676 M | -18.372 M | 376.000 K | -26.182 M | |
| -62.51% | -31.13% | -102.05% | -7,063.30% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -71.146 M | -26.676 M | -18.372 M | 376.000 K | -26.182 M | |
| 62.51% | 31.13% | 102.05% | -7,063.30% |